Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-18

Clinical Trial Update: Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease

View source ↗

Summary

This report outlines the results of a retrospective cohort study evaluating the efficacy of Axona, a medium-chain triglyceride product, in patients with Alzheim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axona (medium-chain triglycerides)

Snippet

Sponsor: Cerecin | Conditions: Alzheimer's Disease | Status: COMPLETED